Suppr超能文献

经皮支架血管成形术治疗肾动脉狭窄的疗效 - 单中心 15 年经验。

Efficiency of Percutaneous Stent Angioplasty in Renal Artery Stenosis - 15 Years of Experience at a Single Center.

机构信息

Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Rofo. 2021 Mar;193(3):298-304. doi: 10.1055/a-1236-4195. Epub 2020 Oct 1.

Abstract

PURPOSE

To determine the therapeutic efficiency of percutaneous revascularization in renal artery stenosis (RAS), as well as the role of comprehensive factors such as patient selection and degree of artery stenosis, on clinical outcome.

METHODS AND MATERIALS

101 patients with hemodynamically relevant RAS underwent percutaneous angioplasty (PTA). 65.7 % were male (mean age: 64 years; range: 18-84). The clinical data was retrospectively analyzed. The serum creatinine (Cr), glomerular filtration rate (GFR), and blood pressure (BP) levels pre- and postprocedural, between 6 months and 1 year, were retrospectively collected and statistically analyzed.

RESULTS

Follow-up data was available in 34 (33.7 %) and 28 patients (27.7 %) for Cr and MAP, respectively. A significant drop in mean arterial pressure (MAP) was observed on follow-up (mean -5.27 mmHg). Higher baseline Cr and MAP values showed a more pronounced drop in the follow-up (Cr: p 0.002; difference to baseline -0.25 mg/dL, 95 %CI:-0.36, -0.07 and BP p < 0.001; diff. to baseline -0.72 mmHg; 95 %CI: -1.4, -0.40). There was no association between comorbidities, gender, and degree of stenosis with renal and BP outcome. No significant improvement in renal function was observed on follow-up (mean Cr drop: -0.015 mg/dL). The age group 51-60 years showed a significant improvement in BP (p 0.030; diff. to baseline -19.2 mmHg; 95 %CI: -34, -4.3). There was a slight reduction in antihypertensive medication following angioplasty (0.2 fewer). Minor complications were recorded in five procedures (4.9 %).

CONCLUSION

Percutaneous renal artery revascularization in the presence of atherosclerotic RAS is a safe procedure associated with a significant drop in post-procedural BP. No significant improvement in renal function was observed. Further prospective studies focused on patient selection are necessary.

KEY POINTS

· Percutaneous stent angioplasty in renal artery stenosis is associated with a significant improvement in post-procedural blood pressure control.. · There is no improvement in renal function after percutaneous stent angioplasty for renal artery stenosis (RAS).. · Percutaneous stent angioplasty is a safe procedure..

CITATION FORMAT

· Guerreiro H, Avanesov M, Dinnies S et al. Efficiency of Percutaneous Stent Angioplasty in Renal Artery Stenosis - 15 Years of Experience at a Single Center. Fortschr Röntgenstr 2021; 193: 298 - 304.

摘要

目的

确定经皮血管成形术(PTA)治疗肾动脉狭窄(RAS)的疗效,以及患者选择和动脉狭窄程度等综合因素对临床结果的影响。

方法和材料

101 例血流动力学相关 RAS 患者接受了 PTA。65.7%为男性(平均年龄:64 岁;范围:18-84 岁)。回顾性分析临床资料。回顾性收集并统计分析术前和术后 6 个月至 1 年的血清肌酐(Cr)、肾小球滤过率(GFR)和血压(BP)水平。

结果

34 例(33.7%)和 28 例(27.7%)患者的 Cr 和 MAP 随访数据可用。随访时平均动脉压(MAP)明显下降(平均下降-5.27mmHg)。较高的基线 Cr 和 MAP 值在随访中下降更为明显(Cr:p<0.002;与基线相比,下降 0.25mg/dL,95%CI:-0.36,-0.07;BP:p<0.001;与基线相比,下降 0.72mmHg,95%CI:-1.4,-0.40)。合并症、性别和狭窄程度与肾脏和血压结果之间无关联。随访时肾功能无明显改善(平均 Cr 下降:-0.015mg/dL)。51-60 岁年龄组的血压显著改善(p<0.030;与基线相比,下降 19.2mmHg,95%CI:-34,-4.3)。血管成形术后降压药物略有减少(减少 0.2 种)。5 例(4.9%)记录到轻微并发症。

结论

在存在动脉粥样硬化性 RAS 的情况下,经皮肾动脉血运重建是一种安全的手术,可显著降低术后血压。血管成形术后肾功能无明显改善。需要进一步进行前瞻性研究,重点关注患者选择。

重点

·经皮支架血管成形术治疗肾动脉狭窄可显著改善术后血压控制。·经皮支架血管成形术治疗肾动脉狭窄(RAS)后肾功能无改善。·经皮支架血管成形术是一种安全的手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验